Nirsevimab Library
This is a collection of current resources related to Nirsevimab.
Access to Respiratory Syncytial Virus Preventive Tools for Neonates and Infants in Europe
This comment discusses the limited access to respiratory syncytial virus (RSV) preventive tools for newborns and infants in Europe. RSV causes millions of pneumonia cases …
Ask aRCie
Advocate to Vaccinate: Moving Away From the "Politics" of Vaccination
2024
· New York Medical College
This policy commentary focuses on promoting vaccines without political influence. It describes efforts to encourage vaccination, especially for children, while avoiding political debates that can …
Women's Acceptance of Two Strategies for Preventing Respiratory Syncytial Virus Infant Bronchiolitis: Maternal Immunization or Monoclonal Antibodies for Newborns
This article explores two ways to prevent respiratory syncytial virus (RSV) bronchiolitis in infants: through maternal immunization or giving monoclonal antibodies to newborns. It describes …
Prevention of RSV Bronchiolitis: An Ethical Issue
2024
· Bambino Gesu Children’s Hospital,
· University of Rome Tor Vergata,
· Bambino Gesù Children Hospital
The article describes the prevention of RSV bronchiolitis in infants using nirsevimab, a newly approved treatment. It highlights Galicia's successful immunization campaign, which significantly reduced …
The Pharmacist, a Key Player in the Fight Against the Respiratory Syncytial Virus
2024
This article highlights the important role pharmacists play in fighting respiratory syncytial virus (RSV), especially for infants and people over 60. It describes two main …
Effectiveness of Nirsevimab in Infants Against Respiratory Syncytial Virus and Related Events
2024
· Kaiser Permanente
This article discusses a study on nirsevimab, a treatment for infants to prevent respiratory syncytial virus (RSV), which is common in lower respiratory tract diseases. …
Formulary Drug Reviews: Nirsevimab
2024
· Washington State University
This article discusses the Formulary Drug Reviews on nirsevimab, a monoclonal antibody for preventing respiratory syncytial virus (RSV) in newborns and infants. It covers the …
Safety and Efficacy of Nirsevimab in a Universal Prevention Program of Respiratory Syncytial Virus Bronchiolitis in Newborns and Infants in the First Year of Life in the Valle d'Aosta Region, Italy, in the 2023-2024 Epidemic Season
This article describes a study on the safety and effectiveness of nirsevimab, a monoclonal antibody, in preventing RSV bronchiolitis in newborns and infants during the …
Impact of Nirsevimab Immunization on Pediatric Hospitalization Rates: A Systematic Review and Meta-Analysis (2024)
2024
· Servizio di Prevenzione e Sicurezza Negli Ambienti di Lavoro (SPSAL),
· University of Palermo,
· APSS Trento,
· University of Parma,
· Turin Local Health Authority
This article reviews the effects of nirsevimab immunization on reducing hospital visits for children. It describes how researchers looked at different studies to see if …
Evaluation of Antibody-Based Preventive Alternatives for Respiratory Syncytial Virus: A Novel Multi-Criteria Decision Analysis Framework and Assessment of Nirsevimab in Spain
2024
· University Carlos III,
· BioMad,
· Fisabio-Public Health,
· Catholic University of Valencia,
· Instituto de Salud Carlos III,
· Weber Foundation
This study evaluates nirsevimab, an antibody-based preventive measure for respiratory syncytial virus (RSV) in Spain. Using a multi-criteria decision analysis framework, experts found that nirsevimab …